MANF : A new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons

Download
  1. Get@NRC: MANF : A new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons (Opens in a new window)
DOIResolve DOI: http://doi.org/10.1385/JMN:20:2:173
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleJournal of Molecular Neuroscience
Volume20
Issue2
Pages173187; # of pages: 15
Subjectbio; cell line; secreted protein; novel protein; type-1 astrocyte; neuroprotection; phenotype specificity
AbstractWe describe the discovery of a novel, 20 kDa, secreted human protein named mesencephalic astrocyte-derived neurotrophic factor, or MANF. The homologous, native molecule was initially derived from a rat mesencephalic type-1 astrocyte cell line and recombinant MANF subcloned from a cDNA encoding human arginine-rich protein. MANF selectively protects nigral dopaminergic neurons, versus GABAergic or serotonergic neurons. The discovery of MANF marks a more systematic approach in the search for astrocyte-derived, secreted proteins that selectively protect specific neuronal phenotypes. Compared to glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF), MANF was more selective in the protection of dopaminergic neurons at lower (0.05–0.25 ng/mL) and middle (0.5–2.5 ng/mL) concentrations: MANF>GDNF>BDNF. GDNF was more selective at higher concentrations (25–50 ng/ml): GDNF>MANF>BDNF. Two domains in MANF of 39-AA and 109-AA respectively, and eight cysteines are conserved from C. elegans to man. MANF is encoded by a 4.3 Kb gene with 4 exons, and is located on the short arm of human chromosome 3. The secondary structure is dominated by α-helices (47%) and random coils (37%). Studies to determine the localization of MANF in the brains of rat, monkey, and man, as well as the receptor, signaling pathways, and biologically active peptide mimetics are in progress. The selective, neuroprotective effect of MANF for dopaminergic neurons suggests that it may be indicated for the treatment of Parkinson’s disease.
Publication date
LanguageEnglish
AffiliationNRC Biotechnology Research Institute; National Research Council Canada; NRC Institute for Biological Sciences
NoteDA - 20030609IS - 0895-8696LA - engPT - Journal ArticleRN - 0 (Brain-Derived Neurotrophic Factor)RN - 0 (DNA, Complementary)RN - 0 (MANF protein, human)RN - 0 (Nerve Growth Factors)RN - 0 (Nerve Tissue Proteins)RN - 0 (Neuroprotective Agents)RN - 0 (glial cell-line derived neurotrophic factor)RN - 51-61-6 (Dopamine)SB - IM
Peer reviewedNo
NRC number37716
NPARC number3538660
Export citationExport as RIS
Report a correctionReport a correction
Record identifier089f5eef-bd52-4280-962f-58fa3b541748
Record created2009-03-01
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)